Citadel Advisors - CERULEAN PHARMA INC ownership

CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 34 filers reported holding CERULEAN PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CERULEAN PHARMA INC
ValueSharesWeighting
Q2 2017$4,000
-86.7%
10,072
-73.1%
0.00%
Q1 2017$30,000
-11.8%
37,396
+133.7%
0.00%
Q2 2016$34,00016,0000.00%
Other shareholders
CERULEAN PHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 3,287,529$6,970,0007.48%
Polaris Venture Management Co IV LLC 1,437,441$3,047,0005.05%
SPHERA FUNDS MANAGEMENT LTD. 450,000$954,0000.25%
Deer VII & Co. Ltd. 166,675$353,0000.16%
Rock Springs Capital Management LP 625,000$1,325,0000.10%
Granahan Investment Management 708,215$1,501,0000.06%
Northeast Financial Consultants Inc 20,000$42,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 202,623$430,0000.01%
WEDBUSH SECURITIES INC 16,000$34,0000.01%
Alyeska Investment Group, L.P. 319,289$677,0000.01%
View complete list of CERULEAN PHARMA INC shareholders